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phospholipid levels in wt WDmice. Phospholipids were visualized using a Nile
Red staining and co-localized with vacuolated tubuli. Oil Red O Staining
showed increased numbers of granulus containing neutral lipids in proximal
tubuli of wildtype Western diet-fed mice. Unexpectedly, no renal lipid
accumulation occurred in Nlrp3ko mice fed a Western Diet. A Western diet
induced cholesterol accumulation in wildtype mice despite decreased uptake,
increased excretion and decreased synthesis based on gene expression analysis.
We propose a novel role for the immune receptor Nlrp3 in mediating renal
cholesterol and phospholipid accumulation during the early development of
Metsyn-driven CKD. Further research is conducted to investigate the
therapeutic potential of Nlrp3 in early renal CKD development.
http://dx.doi.org/10.1016/j.krcp.2012.04.335
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HIGH BODY MASS INDEX (BMI) IS ASSOCIATED WITH ADIPOKINES AND
INSULIN RESISTANCE IN NONDIALYSED CHRONIC KIDNEY DISEASE
(CKD) PATIENTS
Maria Ines Barreto-Silva, Carla Avesani, Laura Kawakami, Renata Martucci,
Rachel Bregman
Rio de Janeiro State University, Brazil
The aim of this study was to assess the association between body
adiposity with adipokines and with insulin resistance in non-dialysed CKD
patients. This is a cross-sectional study including CKD patients under
regular treatment in an outpatient clinic. Glomerular ﬁltration rate was
estimated by MDRD equation (eGFR). The nutritional status was assessed by
BMI, total body fat (BF; dual-energy X-ray absorptiometry), midarm muscle
circumference and serum albumin. Laboratorial parameters included serum
glucose, triglycerides; leptin and insulin (radioimmunoassay); high molecular
weight adiponectin (HMWAdipo; ELISA). The insulin resistance was assessed by
HOMA-IR. Data are expressed as mean þ SD. One hundred and thirty four CKD
patients (male¼56%; eGFR¼ 29713ml/min.; 65712 years old) were
included. None of the patients presented protein energy wasting and most of
them had BMIZ25kg/m2 (overweight/obese group: OwOb) (n¼ 72; 54%). BMI
was correlated with BF (r¼ 0.74; po0.0001). Both BMI groups showed similar
eGFR and CKD stages distribution (stage 3:42%, 4: 37%, 5: 21%), hence the
comparisons were held between groups with normal and OwOb BMI. The
OwOb group had BMI, BF, glucose, triglycerides, leptin and HOMA-IR higher
than normal BMI group (Po0.05), while HMWAdipo was lower in OwOb group
(Po0.05). BMI was signiﬁcantly associated with leptin (r¼ 0.58); HOMA-IR
(r¼ 0.36) and HMWAdipo (r¼ 0.45). HOMA-IR was associated with leptin
(r¼ 0.28) and with HMWAdipo (r¼ 0.29) (Po0.01), even after adjusting for
BF, eGFR, gender and age.
In conclusion, BMI and BF were associated with increased leptin and HOMA-
IR, but with decreased HMWAdipo. The OwOb CKD patients presented higher
risk for metabolic and cardiovascular disorders.
http://dx.doi.org/10.1016/j.krcp.2012.04.336
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INFLAMMATION IS ASSOCIATED WITH EXCESSIVE BODY ADIPOSITY IN
NONDIALYSED CHRONIC KIDNEY DISEASE (CKD) PATIENTS
Maria Ines Barreto-Silva, Carla Avesani, Laura Kawakami, Renata Martucci,
Rachel Bregman
Rio de Janeiro State University
The purpose of this study was to evaluate inﬂammation in non-dialysed
CKD patients with normal and high body adiposity level. One hundred and
thirty four CKD patients (male: 56%; age¼65712 years) under treatment
for 3.072.0 years were evaluated in a cross-sectional study. Glomerular
ﬁltration rate (eGFR) was estimated by MDRD equation. Body adiposity
was assessed by BMI and total body fat (BF; dual-energy X-ray
absorptiometry). Laboratorial measurements were: albumin, pro-
inﬂammatory cytokines by Multiplexed analysis: tumor necrosis factor-a,
interferon-g, high sensitive C reactive protein, monocyte chemotactic
protein, inteleukine 6 and 8, intercellular adhesion molecule-1 and
vascular adhesion molecule-1. The inﬂammation status was deﬁned
according to the median values for each studied pro-inﬂammatory
cytokines: negative for inﬂammation (Inﬂ-) (o median), positive for
inﬂammation (Inﬂþ) (Z median). The cytokines were compared between
patients with normal BMI (o25kg/m2) (46%; BMI¼22.271.9) and high
BMI (Z25kg/m2) (BMI¼28.872.8). Both groups showed similar eGFR and
CKD stages distribution (stage 3:42%, 4: 37%, 5: 21%). BF and all cytokines
were higher in high BMI group than in normal BMI (Po0.0001). BMI and
BF were correlated (r¼ 0.74; Po0.0001). The Inﬂþ condition was more
prevalent, for all cytokines, in the high BMI group (range:61–76%) than in
normal (24–38%). Multivariate logistic regression analysis, for all cytokines,
showed that Inﬂþ condition was associated with high BMI (Odds Ratio
range: 2.5–4.2; 95%CI: 1.1 - 9.6; Po0.01), even after adjusted for age,
gender, diabetes and eGFR. In conclusion, CKD patients with high BMI and
body adiposity are at higher risk for inﬂammation. Therefore, the excess of
adiposity should be carefully treated in these patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.337
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SPANISH MULTICENTRIC STUDY ABOUT NUTRITION-INFLAMATIONHN
WITH MID DILUTION (ENIMID STUDY): PRELIMINARY RESULTS
Barril G, Anaya S, Vozmediano C, Celayeta AO, Novillo R, Garcia-Bernal V,
Beired I, Huarte E, JC Chacon, Martn J, Santana H, Grande J, Chacon JC,
Martin Garcia, Sousa F, Martin J Gago, Sanchez R, Lopez-Montes A, R de
Gracia, Tornero F, Uson J, Pousa M, Cigarran S, Giorgi M, Rdez Cubillo B,
Herrero J, Izdo MJ, Abaigar P
Introduction and aims: The prevalence of malnutrition are 23-76% of ESRD
patients undergoing HD, and 20-50% of them suffers inﬂammation.
Nowadays, the ‘‘malnutrition-inﬂammation’’ duo is frequently found in HD
patients.The aim of this Spanish multicenter study is to evaluate the effects
of the Mid-Dilution HDF on the inﬂammatory-nutritional state, on some
body composition and on the quality of life in the HD patients. The total
number of patients expected 64; the preliminary analysis of 52 patient/3
months and 23 after 6months (the study will last 1 year), is presented.
Methods: Patients undergoing standard HD treatment with High Flux
dialyzers for 4 hours/three times a week passed to HDF Online
MidDilution with OLPUR 220 ﬁlters at a reinfusion rate of 12l/h.The
patients are classiﬁed by: age, gender, Charlson comorbidity index, dialysis
vintage. The parameters analyzed each 3 months are: urea,
b2microglobuline, albumin, pre-albumin, CRP, ﬁbrinogen, IL6, IL10, leptin,
adiponectin, neuropeptide Y, body composition by BIVA parameters and
apetite and quality life surveys.
RESULTS: Patients classiﬁcation:  Age: 64.0670.8 years;  Sex: 64% male;
 Charlson-index: 3.9771.66;  HD vintage 54.7744.8 months.Signiﬁcant
decrease of b2microglobuline pre-dialysis from baseline 26,16 to 20,06 mg/
L (p¼ 0,006) after 3 months and to 17,88smg/L (p¼ 0.09) after 6 months.
xb2microglobulineRR was 82.45 73.20 % and the URR was 79.5673.51 %,
which demonstrates a good removal of medium and small molecules. The
Kt/V remained stable (41,5). Albumin increased from 3.81 g/dL to 3.87 g/
dL in e months and to 3.89 g/dL in the 6 months of evaluation. No
signiﬁcant differences in levels of pre-albumin (xbaseline 28 mg/dl).
Corporal and BIVA parameters evolution These data shown an
improvement of the body composition and water distribution. .Sig.
improvements were seen in the appetite scale in the ﬁrst 6 months
(p¼ 0.09). The total Quality of Life, evaluated in 3 months by SF36,
increased from 55,61 to 50,66 (p¼ 0,05); the physic from 50,28 to 55,92
(p¼ 0,036); the mental from 55,69 to 60,1 (p¼ 0,12).Cytokines:we found
an increase in neuropeptide Y and IL10 and no signiﬁcant changes in leptin
and adiponectin with slight increase of IL6.
CONCLUSIONS: 1-The preliminary results show that MidDilution provides a
good removal of small and middle molecules, increases appetite by
providing a proper balance of cytokines through stimulation of
antiinﬂamatory ones and neuropeptide Y. 2-It provides an improvement of
body composition. Finally MidDilution improves nutritional parameters
which leads to a better quality of life, as well as physical and mental status.
http://dx.doi.org/10.1016/j.krcp.2012.04.338
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LONGITUDINAL CHANGES IN PHASE ANGLE REFLECT CHANGES IN
SERUM IL-6 LEVELS IN MAINTENANCE HEMODIALYSIS PATIENTS
Ilia Beberashvili, Ada Azar, Inna Sinuani, Hadas Kadoshi, Gregory Shapiro,
Leonid Feldman, Zhan Averbukh, Joshua Weissgarten
Assaf Harofeh Medical Center, Zeriﬁn, Israel
We hypothesized that longitudinal changes in phase angle (PA) may have
independent associations with changes in inﬂammatory parameters over
time and consequently with long-term survival in maintenance
hemodialysis (MHD) patients.Dietary energy and protein intake,
biochemical markers of nutrition, body composition (anthropometry and
bioimpedance analysis) and IL-6 as inﬂammatory marker, were measured at
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baseline and at 6, 12, 18 and 24 months following enrollment, in 101
prevalent hemodialysis patients (37% women) with a mean age of
64.6711.5 years. Observation of this cohort was continued over
3 additional years.
Longitudinally, 1O increase in PA over time, controlling for demographic
and clinical parameters, was associated with a delay in longitudinal
elevation of IL-6 (linear estimate: -2.11 (95% CI: -3.47; -0.75) pg/ml/mo;
p¼0.002 for PA X Time interaction). A decrease or increase in PA over
time was associated with inverse linear changes in IL-6 levels (adjusted
r¼-0.305, p¼0.005) and correspondingly with higher or lower death risk.
For each 1O increase in PA, the crude and adjusted mortality hazard ratios
using Cox models with effect of time varying risk were 0.62 (95% CI:
0.54; 0.71) and 0.61 (95% CI: 0.53; 0.71), respectively.
In conclusion, longitudinal changes in PA appeared to be reliable in
detecting changes in nutritional and inﬂammatory parameters over time -
combination that may contribute to understanding of its prognostic bearing.
http://dx.doi.org/10.1016/j.krcp.2012.04.339
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PILOTSTUDY TO EVALUATE THE EFFECT OF PHOSPHORUSBINDERS
ON FGF23
A.Bouma de Krijger, P.M. ter Wee, F.J. van Ittersum, M.G. Vervloet
Dept. of Nephrology,VU University Medical Centre, Amsterdam
The Netherlands Fibroblast growth Factor 23 (FGF23) is independently
associated with cardiovasculair outcome. A reduction of dietary phosphorus
intake in healthy individuals leads to a decrease of FGF23. Data on the potency
of phosphate binders to lower FGF23 in CKD stage 3 are conﬂicting. We treated
18 normophosphatemic CKD stage 3 patients with a ﬁxed dose of sevelamer-
carbonate (Renvelas) 2,4 g powder for suspension, before breakfast and diner.
Patients remained on their usual diet. Laboratory data were collected 2 weeks
prior to baseline, at start of sevelamer, at week 8 following sevelamer treatment
and after a wash-out of 2 weeks. We measured serum phosphorus, PTH, FGF23,
estimated GFR (by the MDRD formula) and 24–h urinary phosphate excretion.
General Estimated Equation was used to evaluate the effect of
phosphorusbinding on 24–h urinary phosphate excretion and on FGF23.
patientcharacteristics
n 18
Age(year) 54 (46,1-62,2)
Sex (m/f) 7 / 11
race (% caucasian) 66
eGFR (ml/min/1.73m2) 41.2 7 9.6
FGF23 (U/l) 158 (116-216)
PTH (pmol/l) 7.5(5,4-41,8)
Phosphate (mmol/l) 1.09 7 0.19
Proteinuria (g/24 h) 0,7 (0,2-1,6)
Results are as follows; phosphorus binding by sevelamer signiﬁcantly
lowered urinary phosphate excretion, from a median of 26.25 mmol/24 h
to 17.5 mmol/l. Other parameters showed no sgniﬁcant association with
urinary phosphate excretion. The serum phosphate was unchanged during
treatment. Creatinin clearance was signiﬁcantly associated with FGF23
(p0.03). FGF23 did not change signiﬁcant following phosphorus binding
therapy. In conclusion; although 8 weeks sevelamer treatment signiﬁcantly
lowered 24 h urinary phosphate excretion, there was no reduction in
FGF23 levels in this group of CKD stage 3 patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.340
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NUTRITION AND HEMODIALYSIS: THE ASSOCIATION OF DIETITIAN
INTERVENTION TOWARDS ACHIEVING QUALITY PATIENT
DIALYSIS OUTCOMES
archied bunani ali mohammed lehbi
The National Kidney Foundation has recognized nutritional interventions as
building blocks of better dialysis outcomes. This study investigated the
inﬂuence of Dietitian Intervention on mortality, adherence to dialysis
prescriptions, and Quality Patient Dialysis Outcomes. The Subjective Global
Assessment (SGA) tool was used to identify ratings and these ratings were
associated to the tendency of risk towards mortality using a hazard ratio of 95%
conﬁdence interval in cox regression using SPSS v.19. Results revealed that
respondents whomarked signiﬁcantly as C (1) in the Functional Capacity Items
– Dysfunction (sp¼1.45) showed highest risk (17.5% risk) towards mortality.
This implied that these individuals despite of Dietitian Interventions, mortality
were increased related to co-morbidities. Respondents who had changes on
eating habits in a typical breakfast, lunch, dinner compared from the last 6 months
and those who, during physical examination, had ankle edema showed higher
risk (sp¼1.40) towards mortality at 3.44%. Respondents who showed a B (2) on
metabolic demand (stress) and those with muscle wasting (quadriceps, deltoids)
showed a 2.14% mortality risk (sp¼1.37); lower than those with dysfunction.
Results further indicated that respondents who have higher spKt/V (sp¼1.58)
showed an SGA rating of A (3) and noted to have lowest risks towards
mortality and other co-morbidities.
Quality Dialysis
Patient Outcomes
Hazard Ratio (95% Conﬁdence Interval)
SGA Rating Correlation DESCRIPTION
Indicators
Sp Kt/V (o1.2 ¼
41.2)
1.58 0.87 STRONG
Dysfunction 1.22 0.66 STRONG
Changes of Eating
Habits
1.36 0.72 STRONG
Metabolic demand 1.36 0.78 STRONG
In conclusion, an inﬂuence of Dietitian Intervention was notable to all
patients receiving dialysis treatments. The Clinical Dietitian’s facility in
assisting dialysis patients on the proper diet to be taken associated to
condition will enable the individual to lower mortality risk ratio.
http://dx.doi.org/10.1016/j.krcp.2012.04.341
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NUTRITION-RELATED PREDICTORS OF SLEEP DURATION IN
HEMODIALYSIS PATIENTS
Jerrilynn Burrowes 1, Greg Russell 2, Mark Unruh 3, Michael Rocco 2
1 Long Island University (LIU) Post, Brookville,NY
2 Wake Forest School of Medicine, Winston-Salem, NC
3 U of Pittsburgh, Pittsburgh, PA, USA
We have previously shown that poorer appetite was a signiﬁcant predictor
of decreased sleep quality (SQ) among maintenance hemodialysis (MHD)
patients. There is a gap in the literature when examining sleep duration (SD)
in MHD patients and the variables that may predict SD. Using data from the
HEMO Study, demographic, case mix, nutrition-related and quality of life
(QOL) variables were explored as predictors of SD in 1805 MHD patients. Self-
reported SD (in hrs) in the last 24 hrs was assessed annually using questions
from the KDQOL instrument. A multinominal logistic regression analysis was
conducted to determine whether SD (short 0–6; medium 7–9; or long 10þ)
was associated with the selected variables and Kt/V and ﬂux randomized
assignments in a longitudinal (repeated measures) model.
At baseline, mean SD was 7.872.4 hrs; 33%, 43% and 24% of subjects were in
the short, medium and long sleep groups, respectively. In univariate analysis,
dietary protein intake, serum albumin, appetite, and QOL measures (mental
component score [MCS] and physical component score [PCS]) were signiﬁcant
predictors of SD. In multivariate analysis, age (P¼0.008), race (White vs. Black)
(P¼0.001), appetite on dialysis days (DD) (P¼0.0001), MCS and PCS
(Po0.0001, respectively) were also signiﬁcant predictors of SD. Younger
patients and those with good appetite on DD were more likely to sleep less,
whereas Blacks and those with higher MCS and PCS were more likely to sleep
more. Of the nutrition variables, higher protein intake and better appetite were
associated with long vs. short SD in univariate analysis. In multivariate analysis,
appetite on DD was the only variable predictive of SD. The odds ratio (95% CI)
of having a good appetite for those in the short SD group compared to the
medium and long SD groups was 0.81 (0.72, 0.92) and 0.86 (0.78, 0.95),
respectively. Further research on SD and appetite and the potential effects of
short sleep on inﬂammation needs to be done in MHD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.342
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